CXCL8 and respiratory system disorder: Numerous reports linked CXCL8 to respiratory diseases like COPD, and Genentech had developed a CXCL8 neutralizing antibody that it thought might be useful therapeutically to treat respiratory diseases like emphysema, bronchitis, and COPD.